Open fractures are common and devastating injuries that can lead to posttraumatic osteomyelitis, a significant clinical problem that often results in non-union, multiple surgeries, disability, and ultimately, amputation. Open fractures are extremely challenging due to (i) bone loss, (ii) contamination, and (iii) soft tissue damage. In Gustilo grade II and grade III open fractures, infection rates have been shown to reach as high as 10% and 50%, respectively. Current treatment options include autografts, allografts and distraction osteogenesis. These treatment options have significant complications, unsatisfactory success rates, and do not provide a way to prevent or treat osteomyelitis.
METHODS:
Thirty-two adult male Brown Norwegian rats weighing between 250g and 300g were used. A modified drop weight apparatus was used to create a segmental bone defect. Muscle crush injury was replicated by raising the lower stage and applying a pressure of 20 psi to the fracture site for 5 minutes immediately after the fracture was created. Comminuted bone was surgically removed to create a 5mm bone gap and the wound was inoculated with Staphylococcus aureus at 10 4 and Escherichia coli at 10 2 . All fractures were then stabilized using a threaded intra-medullary K wire. All rats received a cylindrical, biodegradable scaffold made from polypropylene fumarate (PPF).
Each scaffold was loaded with 10µg rhBMP-2, placed into the segmental defect, and the K wire was passed through the center. Gentamicin was applied to the scaffolds immediately after placement in the gap. Gentamicin was used due to low toxicity in rats, bactericidal activity, and broad spectrum coverage. Ten rats received no gentamicin (control), a low dose groups received 10mg gentamicin (n=12), and a high dose group received 20mg gentamicin (n=10). In vivo radiographs were obtained immediately post-op and at weeks 1, 3, and 6 and examined for radiographic evidence of osteomyelitis and fracture gap healing.
RESULTS:
One rat from the control group has died from presumed sepsis at 48h post op. At one week post-op, all rats from each group showed little or no signs of callus formation. One rat from the control group showed signs of lytic bone lesion (early osteomyelitis).
Three week and six week infection rates are shown in Table I . The rate of bridging callus formation at weeks 3 and 6 are shown in Table II . By six weeks the majority of rats in the low dose group showed fracture healing and no evidence of osteomyelitis. In contrast the majority of both the control and the high dose groups showed considerable radiographic evidence of osteomyelitis and all lacked bridging callus. The majority of the bone scaffolds withstood weight bearing and remained intact at 6 weeks.
DISCUSSION:
Our results suggest that gentamicin applied to a biodegradable PPF scaffold is effective at decreasing osteomyelitis in an infected open fracture. The scaffold provided structural support and delivered the BMP-2 necessary to heal a large bone defect. Both the low and high dose gentamicin groups showed decreased rates of infection compared to that of the control group. It was expected that the high dose group would show a reduction of infection rate equal to or greater than that of the 10mg group, but this was not seen. We hypothesize that the high dose may have reached a cytotoxic level, leading to decreased activity of leukocytes as well as osteoblasts.
The two scaffolds showing resorbtion and scaffold breakdown were in rats receiving 10mg gentamicin and whose radiographs showed bridging callus formation and no signs of infection.
Development of osteomyelitis in open fractures is a major concern of orthopedic surgeons because it is difficult to treat and has devastating consequences. This study has shown that a biodegradable, load-bearing scaffold can act as an effective delivery system for both locally concentrated antibiotics, as well as biologically active proteins. This highly clinically relevant concept merits further study. 
